3185 results for «600145»
3185 results
TAVI: new evidence and clinical trials
14 Feb 2026 – From PCR Tokyo Valves 2026
This session reviews the latest evidence from head-to-head clinical trials comparing contemporary TAVI devices, including detailed discussions of the LANDMARK and COMPARE trials. It also highlights ongoing and upcoming clinical trials poised to influence guideline recommendations and expand the therapeutic scope of TAVI, providing crucial insights...
Team approach to structural heart disease: how to handle unexpected situations
14 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the multidisciplinary team approach to managing structural heart disease, focusing on responses to unexpected intraoperative and postoperative situations. It features real-world experiences from a TAVI radiologic technologist, clinical engineer, TEER sonographer, and TEER nurse, emphasizing their respective roles in addressing intraoperative events, sudden...
From diagnosis to device: decision-making and planning for mitral valve interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers a structured approach to mitral TEER, integrating advanced imaging techniques for detailed mitral valve morphology evaluation, procedural planning, and complication prediction. It highlights device selection considerations and emerging technologies to tailor interventions for complex mitral valve disease, supported by multiple case presentations and...
Healthcare professionals in the structural heart disease treatment
15 Feb 2026 – From PCR Tokyo Valves 2026
This session highlights the essential roles and contributions of various healthcare professionals involved in structural heart disease treatment. It offers insights into the unique responsibilities of medical technologists, nurses, and radiological technologists across preoperative, intraoperative, and postoperative stages, fostering collaboration and sharing practical tips to strengthen...
Complications and bailout strategies in transcatheter mitral interventions
15 Feb 2026 – From PCR Tokyo Valves 2026
This session addresses complications arising during transcatheter mitral edge-to-edge repair (TEER), focusing on identification, anticipation, and management strategies. It also highlights the importance of case selection to improve procedural safety, supported by detailed case analyses covering leaflet/device, access/septal, and hemodynamic complications.
Contemporary approach in the treatment of calcified coronary artery disease
28 Feb 2026 – From Euro4C Annual Meeting 2026
Adopt a contemporary approach to managing calcified coronary artery disease by leveraging high-definition IVUS for lesion assessment and morphology evaluation. Learn to tailor calcium modification strategies based on IVUS findings and combine available tools to optimize treatment outcomes according to patient and lesion profiles.
Transcatheter electrosurgery and leaflet modification of the aortic valve
15 Feb 2026 – From PCR Tokyo Valves 2026
This session offers an expert overview of transcatheter electrosurgery and leaflet modification techniques for aortic valve interventions, focusing on TAV-in-SAV scenarios. It reviews patient selection, procedural setup, and material preparation, with detailed step-by-step guidance on BASILICA and UNICORN techniques, supported by recorded cases and troubleshooting strategies...
Welcome to the Euro4C Annual Meeting 2026
27 Feb 2026 – From Euro4C Annual Meeting 2026
This introductory session sets the stage for a comprehensive exploration of interventional cardiology topics, providing attendees with an overview and framework for the upcoming educational content.
Algorithm approach for severe calcified lesion, what is new?
27 Feb 2026 – From Euro4C Annual Meeting 2026
This session presents the latest algorithmic approaches for managing severe calcified lesions. Attendees will learn to recognize plaque morphologies using intravascular imaging, evaluate the capabilities of current imaging technologies, and understand updated guideline recommendations for optimal treatment strategies.
Complications and bailout strategies in transcatheter mitral edge-to-edge repair
16 Nov 2025 – From PCR London Valves 2025
This session addresses common complications encountered during transcatheter mitral edge-to-edge repair (TEER) and outlines device-specific bailout strategies. Expert operators share essential tips and tricks to recognize and manage these challenges effectively, ensuring optimized procedural safety and success.
Complications of LAA closure - Avoidance and management
17 Nov 2025 – From PCR London Valves 2025
Focused on the prevention and management of complications in left atrial appendage (LAA) closure, this session covers recognition of key procedural risks, techniques for safe transseptal puncture, and strategies to prevent and address device embolisation, pericardial effusion, residual leaks, and device-related thrombus, ensuring procedural safety and...
How to manage complications of tricuspid interventions
18 Nov 2025 – From PCR London Valves 2025
This session focuses on the risks and management of complications arising from tricuspid valve repair and replacement procedures. Participants will learn preventive strategies during transcatheter interventions and become familiar with bailout techniques essential for resolving procedural complications effectively and safely.
Meet the masters: complex mitral TEER
17 Nov 2025 – From PCR London Valves 2025
This session brings together leading mitral transcatheter edge-to-edge repair (TEER) operators for an interactive discussion emphasizing practical aspects of complex procedures. It provides valuable guidance on case selection, procedural strategies, and management of complications, aimed at enhancing the clinical practice of TEER.
Meet the masters: complex TAVI
16 Nov 2025 – From PCR London Valves 2025
This session offers an in-depth exploration of complex Transcatheter Aortic Valve Implantation (TAVI) procedures, emphasizing practical aspects crucial for daily clinical practice. Expert TAVI operators share their extensive experience, providing valuable tips and tricks on case selection, procedural strategies, and managing complications to optimize patient outcomes.
Mitral TEER masterclass
16 Nov 2025 – From PCR London Valves 2025
This masterclass provides a comprehensive framework for mitral Transcatheter Edge-to-Edge Repair (TEER), covering imaging-guided procedural planning, device selection, and deployment. It emphasizes recognition of anatomical challenges and strategies to avoid and manage complications such as single leaflet device attachment, ensuring optimal outcomes.
Newsflash: the best of TCT 2025
17 Nov 2025 – From PCR London Valves 2025
Stay informed with the latest highlights and key advancements from TCT 2025. This session distills the most impactful clinical data, innovative techniques, and emerging trends presented at the conference, providing essential updates for interventional cardiology practice.
Patient-tailored TAVI in bicuspid and tricuspid aortic stenosis
16 Nov 2025 – From PCR London Valves 2025
This session focuses on patient-tailored TAVI strategies for bicuspid and tricuspid aortic stenosis. It reviews recent comparative studies of TAVI devices, discusses the development of individualized TAVI programs for tricuspid aortic stenosis patients, and provides guidance on selecting optimal devices for those with bicuspid aortic valve...
PCR London Valves 2025 Closing Ceremony
18 Nov 2025 – From PCR London Valves 2025
The PCR London Valves 2025 Closing Ceremony provides a reflective and conclusive overview of the event, highlighting key advancements and collaborative efforts in the field of structural heart interventions. This session encapsulates the progress made during the congress and sets the stage for future innovations and...
Prevention and management of TAVI complications
17 Nov 2025 – From PCR London Valves 2025
This session is dedicated to the prevention and management of complications associated with transcatheter aortic valve implantation (TAVI). Participants gain critical knowledge on managing vascular access challenges, anticipating and preventing valve malposition, handling device embolism, and evaluating coronary obstruction risks with effective prevention and bailout strategies.
Redo TAVI for transcatheter heart valve failure
18 Nov 2025 – From PCR London Valves 2025
This session addresses the critical considerations involved in re-do TAVI procedures for transcatheter heart valve failure. It guides through key decision-making processes, step-by-step CT analysis for procedural planning, and established protocols to effectively execute valve-in-valve interventions, enhancing outcomes in complex repeat valve therapies.
